Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Therapeutics > Exam 3: Diabetes pt 2: Insulin Tx > Flashcards

Exam 3: Diabetes pt 2: Insulin Tx Flashcards

1
Q

Solutions approved for IV use

A

Aspart, glulisine, lispro, and regular insulin

Regular insulin is the insulin used as the IV formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NPH as a suspension

A

Cloudy
-Top is clear - bottom is a white section
Shake it and it looks like milk
NOT AN IV SOLUTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clear solutions that you cannot give as IV

A

Glargine
Precipitates at high physiological pH
Makes a snowflake under the skin

Degludec
Can cause severe hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ultra Short acting insulin

A

Aspart (Novolog, Novolog Flexpen, Fiasp)

Lispro (humalog, Humalog KwikPen U-100 and U-200)

Glulisine (Apidra, Apidra solostar)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Short acting Insulin

A

Regular (Humulin R, Humulin N - both U-100)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intermediate acting Insulin

A

NPH (Humulin N, Novolin N)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Long-acting insulns

A

Glargine (Lantus, Lantus Solostar, Basaglar, Rezvoglar, Semglee®)
[all U-100]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ultra long acting insulin

A

Degludec (Tresiba®U-100)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Important to remember with NPH

A

Delayed peak
-Take dose at breakfast - kicks in around lunch
-Helpful if someone cannot take a dose at lunch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulins compatibility

A

Shorts and intermediate - compatible

Long are not compatible with anything

Long acting/ultra long acting - no peak effect, cannot respond to meal time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin premixes

A

NPH/Regular mixture 70/30 (Humulin 70/30, Humulin 70/30 Pen,
Novolin 70/30)

75% neutral protamine lispro (intermediate activity like NPH) / 25% lispro (Humalog Mix 75/25, Humalog Mix 75/25 KwikPen)

50% neutral protamine lispro / 50% lispro (Humalog Mix 50/50, Humalog Mix 50/50 KwikPen)

70% aspart protamine suspension / 30% aspart (Novolog Mix 70/30 Novolog Mix 70/30 FlexPen)

Degludec U-100 / aspart U-100 (Ryzodeg 70/30)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Route of admin

A

IV > IM > SubQ
Intranasal might be fastest - we do not usually use it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Site of injection for insulins

A

Stomach is the fastest

Butt and Thigh are the slowest
-Keep sites of injection consistent
-Might need to rotate injection sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Preparation/mixtures

A

Short-acting effect of insulins may be lost if mixed incorrectly

U-500 regular insulin has a delayed onset, peak, and a long duration of action when compared to U-100 insulin, but its smaller volume often allows for overall increased absorption
If mixing insulins, always use short acting first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin dosing property

A

Lower dose absorbed more rapidly
-When patient is using 100, then switch to 5000, 500 is going to be absorbed better (500 is more of a dose but in a smaller volume)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patient compliance and insulin

A

Correct dose, timing, relation to meals, etc.
TIMING - purpose of insulin is to cover your meal glucose surge - smack sugar down and keeps it level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Patient errors and insulin

A

Dialing/drawing up insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Irregular diet and exercise

A

Will affect absorption and patient response
If they fast, can mess up insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Renal function

A

Renal failure decreases insulin clearance, thereby increasing insulin action
Greater risk of hypoglycemia
15-20% of insulin metabolism occurs in the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Stress

A

Increased insulin clearance
Stress - blood sugars increased; making more hormones: Also have less insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drug interactions

A

Does not necessarily mean we will remove the medications - important to be aware

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Insulin vials stable at room temp for

A

28 days (no exposure to extreme temps) - **90 day supply - keep in fridge

Insulin pens are variable

Refrigerate vials/pens nor in use and DO NOT FREEZE

discard opened insulin vials/pens after 28 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prefill insulin stability

A

Insulin your prefill in syringes is stable for 28 days with refrigeration as long as not mixed

Insulin you prefill in syringes is stable for 10-28 days at room temperature - highly variable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mixed insulin stability

A

Regular/NPH: 7 days in fridge; DRAW UP SHORT FIRST

Aspart, Glulisine, or Lispro with NPH: GIVE IMMEDIATELY - cannot stay a long time

Degludec and Glargine with any other insulin: Never mix with other insulin

25
Q

Complications of insulin therapy: Hypoglycemia - causes

A

Increased insulin dosage - overshot, be conservative initially (sometimes patients do it themselves)

Decreased caloric intake - patient goes on a diet and didn’t tell us

Increased muscle utilization - increased exercise

Excessive alcohol - can cause hypoglycemia

26
Q

Hypoglycemia classification

A

Level 1: Glucose < 70mg/dL - minor
Level 2: Glucose <54 mg/dL - moderate
Level 3: Severe event with altered mental and/or physical functioning needing another person for recovery

27
Q

Signs/symptoms of hypoglycemia

A

Tremors, diaphoresis, anxiety, dizziness, hunger, tachycardia, blurred vision, weakness/drowsiness, headache, irritability, confusion, slurred speech

Beta blockers can decrease responsiveness to hypoglycemia due to blocking sympathetic warning symptoms
Some signs and symptoms will be mased by B blockers
Does not mean we should not use B blockers in diabetic patient

28
Q

Hypoglycemia treatment: Rule of 15’s

A

First thing to do - check blood sugar

Start with 15 gm of fast-acting carb (unless BS < 50mg/dL then use 30 gm)-> level 2

Wait 15 minutes, check BS again; if BS is not >70 mg/dL, repeat with another 15 gm

Examples of what to eat:
*4-5 oz OJ, 4-6 oz cola (half a can), 5-6 lifesavers, 4tsp sugar(white or brown), 1 T honey,
*Glucose tabs 4-5 gm CHO/tabs) or gel

Follow with complex carb
(30 gram)

Glucagon for level 2 or 3 patients:
– 3 mg intranasal Baqsimi
– 1 mg SQ, IM, or IV glucagon (Gvoke Hypopen, GlucaGen®)
– 0.6 mg SQ dasiglucagon (Zegalogue®)

29
Q

Insulin analogs; ultra-short: Glulisine, Lispro or Aspart Advantages

A

Decreases post-prandial and superior postprandial lowering of BS

Fewer overall occurrences of hypoglycemia, less nocturnal hypoglycemia

Greater flexibility

30
Q

Insulin analogs; ultra-short: Glulisine, Lispro or Aspart Disadvantages

A

Risk of hypoglycemia if no meal within 15 minutes of dose - IF YOU DO NOT EAT FAST ENOUGH

Will need to combine w/a longer acting insulin for optimal BS control

If mixed with another insulin, give immediately after mixing

Hyperglycemia/ketosis may occur more rapidly if insulin delivery is interrupted

31
Q

Long-Acting/Ultra Long-Acting Insulins: Glargine or degludec insulin: Advantages:

A

Provide s24+ hour coverage with a constant absorption pattern and no pronounced peak

May be beneficial in patients suffering from nocturnal hypoglycemic episodes

32
Q

Long-Acting/Ultra Long-Acting Insulins: Glargine or degludec insulin: Disadvantages

A

Risk of malignancy Associations seen for an increased cancer risk (breast cancer and possibly colon and pancreatic cancer) among patients taking glargine insulin vs. other types
Other trials have not demonstrated this risk
Can NOT be mixed with any other insulin

33
Q

Glargine vs Degludec

A

i.T2DM w/ either CVD or risk factors for CVD
ii.Cardiovascular risk
1.CV death: 3.6% vs. 3.7%, degludec & glargine, respectively (p = 0.71)
2.Nonfatal MI: 3.8% vs. 4.4% (p = 0.15)
3.Stroke: 1.9% vs. 2.1% (p = 0.50)
iii.Secondary outcome of hypoglycemia
1.Severe hypoglycemia: 4.9% degludec vs. 6.6% glargine (p<0.001)
*If patient can afford to switch to degludec, want to suggest – less risk of hypoglycemia

34
Q

Changing between U-100 therapies

A

If patients change from daily NPH to glargine/degludec, keep dose the same

If patients change from BID NPH to glargine/degludec, Lower dose by 20%
-32 U/day for twice daily

35
Q

Changing U-100 to a concentrated insulin therapy

A

If patients change from BID NPH to U-300 glargine, lower dose by 20%

1:1 conversion between daily glargine to daily glargine (Toujeo) but patients may need an increased dose of the Toujeo or Toujeo Max

1:1 conversion btw basal insulin and U-200 insulin degludec

1:1 conversion btw lispro U-100 to U-200

U-100 basal-bolus regimen to U-500 regimen, may require 20% dosage reduction depending on BS readings/A1C

36
Q

Assessing A1C (8%, 8-10%, >10%)

A

If A1C is <8%:
-Lower TDD by 10-20%

If A1C is 8-10%
-Keep same TDD

If A1C is >10%
-Increase TTD by 10-20%

37
Q

If TDD 150-300 units

A

Change to BID or TID dosing

BID: 60% before breakfast and 40% before dinner

TID: 40% before breakfast, 30% before lunch, 30% before dinner (0r 45-35-20)

38
Q

IF TDD 300-600

A

Change to TID dosing
May consider 10% dose at bedtime for 4th injection

39
Q

If TDD > 600 units

A

30% breakfast, 30% lunch 30% dinner - 10% bedtime

40
Q

Insulin dosing in T1DM

A

Average total daily dose is 0.4-1 units/kg/day (actual body weight)
-Higher amounts during puberty, menses, and medical illness

41
Q

Why do we use lower doses in newly diagnosed patients

A

Honeymoon phase 0.2-0.6 units/kg/day
Pancreas suddenly remembers it can make insulin again - does not last
The younger they are the more pronounced it is

42
Q

How often should T1DM patients check blood sugars

A

4 times daily (before meals and bedtime)
Occasionally at 3AM to assess insulin dosages

43
Q

Basal Bolus dosing T1DM

A

Basal is provided by either 1-2 doses of Glargine or Degludec or 1-2+ doses of NPH
Basal will prevent DKA
50-70% of the insulin requirements are usually given as basal insulin while the other 30-50% is divided among the meals as bolus insulin (VARIABLE)

44
Q

T1DM: Prandial doses can be adjusted based on

A

Carbohydrate content of meals; a good starting point is 1 unit for every 15 grams of CHO (1:15 insulin: CHO ratio)

45
Q

Two daily injections of a mix of intermediate insulin (NPH) and short-acting (less common now with ultra-short acting insulins) (only two shots)

A

Split daily dosing:

AM: 40% NPH + 15% short-acting
PM: 30% NPH + 15% short-acting

46
Q

Insulin pumps Type 1 diabetes

A

Provide increased flexibility in dosing and may improve quality of life. Initiation of pump therapy depends on the patient’s preference lifestyle and self-care capabilities
-Rapid acting insulin used to cover both basal and prandial insulin needs
-Basal rate throughout the day
-Use bolus dose calculator to determine bolus doses based on glucose levels, carb intake, and insulin on board

47
Q

T2DM patients insulin

A

Usually LA (glargine or degludec) or intermediate (NPH) is started in combination with non-insulin agents
-Bedtime insulin helps suppress hepatic glucose production at night
-Eventually some orals (esp sulfonylurea) may be D/C if bolus is added

48
Q

Starting basal insulin dose for T2Dm

A

ADA:
0.1-0.2 units/kg/day OR 10 unirs/day

AACE: If A1C <8%, start 0.1-0.2 units/kg/day
If A1C >8%, start 0.2-0.3 units/kg/day
10-15 units

49
Q

Adjusting insulin dose in T2Dm

A

ADA: increase the dose by 2 units every 3 days to reach FBS goal

AACE: Titrate every 2-3 days based on blood glucose level

> 180 mg/dL: add 20% of TDD

140-180 mg/dL: add 10% of TDD 110-139 mg/dL: add 1 unit

<70 mg/dL: decrease by 10-20% of TDD

<40 mg/dL: decrease by 20-40% of TDD

50
Q

For type 2 patients, consider addition of

A

Bolus, especially for patients on >0.5 units/kg/day

Usually can start with 10% of basal dose or 4 units of ultra-short/short acting insulin w/largest meal

Start with biggest meal

Adjust dose by 10-15% every 3-4 days

Can pull someone from the basal dose if needed to prevent hypoglycemia

51
Q

General dosing principles for insulin

A

For ALL diabetic patients on insulin: Increase/decrease dose every 2-4 days until goals are met

Target FBS initially, then PPG
-With A1C > 10%, 70% of the problem involves FBS
-With A1C <7.5%, 70% of the problem involves PPG

Once the basic insulin dose is established and the patient understands how to adjust insulin, the patient can be taught how to adjust their own insulin dose

52
Q

Insulin to carb ratio

A

Amount of short acting insulin needed to cover a patient’s meal (or snack)
Average may be 1 unit: 10-15 gm CHO for adults, and 1 unit: 20-30 gm for school-aged children
NOT ONE SIZE FITS ALL

53
Q

Rule of 500

A

500 divided by total daily insulin dose (basal and bolus) this will equal the amount of grams of CHO for 1 unit of insulin
EX:

500/40 = 12.5

This means, 1 unit of insulin will be needed for every 12.5 gm CHO -> round
Round up to be conservative

54
Q

Correction factor: Rule of 1800

A

For patients taking Short acting insulin
1800/TTD of insul = # of mg/dL blood glucose will drop for every 1 unit of insulin

55
Q

What number do we use for patients on Regular insulin

A

1500

56
Q

Somogyi effect

A

Nocturnal hypoglycemia with Rebound hyperglycemia
-Check BS at 3 am and ask about signs and symptoms
-Add a bedtime snack
-If applicable, move NPH from dinner to bedtime or decrease LA dose at HS

57
Q

Special situations: Sick day management

A

Let friend/relative know that you are sick so they may periodically check in
-Continue insulin even if food intake is decrease
-Stress of illness often increases insulin requirements
-Maintain fluid intake (drink 12 8 oz glasses/day esp if fever present)
Test BG every 4 hours at minimum
Test urine ketones with each urination
-Supplemental doses of insulin 1-2 units for every 30-50 mg/dL over 120mg/dL

58
Q

Seek medical attention if:

A

Urine ketones are present and BG is > 250 mg/dL
-breathing becomes difficult
-fruity odor on breath
-excessive thirst and frequent urination
-mental status changes
-vomiting, repeatedly

Therapeutics (61 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions